l carnitine tmao koeth 2013 nature medicine Gut Microbiota-Derived TMAO: A Causal Factor Promoting Atherosclerotic Cardiovascular Disease? γ-Butyrobetaine Is a Proatherogenic Intermediate

Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of L Carnitine to TMAO: Cell Metabolism Characterization of TMAO productivity from carnitine challenge facilitates personalized nutrition and microbiome signatures discovery Microbiome Springer Nature Link TMAO metaorganismal pathway and chronic inflammatory diseases Revisiting the Role of Carnitine in Heart Disease Through the Lens of the Gut Microbiota PMC Unraveling the Formation Mechanisms of Trimethylamine N Oxide and Its Inhibition by Food Ingredients: Toward Cardioprotective Food Development Journal of Agricultural and Food Chemistry The gutbrain axis and trimethylamine N oxide: an emergent biomarker in neurological diseases ScienceDirect

SKU: 13354455419 · From dearkhaled.com